Technical Analysis for RTTR - Ritter Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.17 -15.42% -0.03
RTTR closed down 15.42 percent on Monday, November 18, 2019, on 34 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical RTTR trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -15.42%

Older signals for RTTR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal, and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. RP-G28 has been studied in a Phase 2a clinical trial. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.
Medicine Medical Specialties Therapeutic Products Metabolic Diseases Bacteriology Therapeutic Digestive System Inflammatory Large Intestine Milk
Is RTTR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.35
52 Week Low 0.16
Average Volume 1,200,037
200-Day Moving Average 0.7554
50-Day Moving Average 0.3227
20-Day Moving Average 0.2503
10-Day Moving Average 0.2358
Average True Range 0.036
ADX 16.3
+DI 14.101
-DI 30.2307
Chandelier Exit (Long, 3 ATRs ) 0.2075
Chandelier Exit (Short, 3 ATRs ) 0.268
Upper Bollinger Band 0.305
Lower Bollinger Band 0.1956
Percent B (%b) -0.23
BandWidth 43.707551
MACD Line -0.0411
MACD Signal Line -0.0417
MACD Histogram 0.0006
Fundamentals Value
Market Cap 2.51 Million
Num Shares 14.8 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -0.13
Price-to-Sales 0.00
Price-to-Book 1.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.25
Resistance 3 (R3) 0.25 0.23 0.23
Resistance 2 (R2) 0.23 0.21 0.23 0.23
Resistance 1 (R1) 0.20 0.20 0.19 0.20 0.22
Pivot Point 0.18 0.18 0.18 0.18 0.18
Support 1 (S1) 0.15 0.16 0.14 0.15 0.12
Support 2 (S2) 0.13 0.15 0.13 0.11
Support 3 (S3) 0.10 0.13 0.11
Support 4 (S4) 0.10